Myeloma Patients Europe (MPE) is proud to present its Year in Review 2024, highlighting achievements and milestones that reflect our commitment to improving outcomes and quality of life for myeloma and AL amyloidosis patients.

This report showcases MPE’s expanded efforts to represent patient needs in European health policy, generate robust evidence that will improve patient experiences, address access challenges across Europe, deliver tools and resources that help empower member organisations, and more.

As we look forward to the upcoming year, we remain dedicated to growing these efforts and driving improvements in patient treatment, care and access across Europe.

Download the PDF here.